Washington — Commercial motor vehicle inspectors will not observe a “soft enforcement” grace period for drivers still using automatic onboard recording devices to track their hours of service after Dec. 16, and such drivers will be placed out of service for violating Federal Motor Carrier Safety Administration regulations, the Commercial Vehicle Safety Alliance warns in a Dec. 2 press release.

Washington — The Commercial Vehicle Safety Alliance is evaluating its next course of action after the Federal Motor Carrier Safety Administration on Sept. 18 denied a CVSA petition requesting that the agency update its definition of “personal conveyance” and clarify a mileage limit.

Greenbelt, MD — Commercial motor vehicle inspectors across North America conducted 38,117 brake system inspections and identified 5,059 vehicles – or 13.3% – with out-of-service conditions during the Commercial Vehicle Safety Alliance’s annual Brake Safety Week, the organization announced recently.

Greenbelt, MD — The results are in for the Commercial Vehicle Safety Alliance’s annual Brake Safety Week.

Greenbelt, MD — The results of the Commercial Vehicle Safety Alliance’s annual Brake Safety Week are in.

The private-label line features a range of nutritious yet tempting snack options.

Dena Lynn Lodato, DVM, MS, DACVS, CCRP, shared her professional achievements and industry expertise in Forbes

Together with prior deals, Delaware now expects to recover a quarter-billion dollars to combat opioid crisis Attorney General Kathy Jennings today announced that she has finalized settlement agreements with CVS and Walgreens, bringing the national amount from investigations and litigation against the pharmaceutical industry for its role in the opioid crisis to more than $50 billion. Delaware’s […]

Delaware to receive nearly $70 million to fight the opioid crisis Delaware Attorney General Kathy Jennings today announced the final approval of $17.3 billion in opioid agreements with drug makers Teva and Allergan and pharmacies CVS and Walgreens. Following successful state sign-on and subdivision sign-on periods, the defendants have committed to the deal and will start releasing funds […]

Value-based care contracting is especially difficult for behavioral health providers, Taft Parsons III, chief psychiatric officer at CVS Health/Aetna, pointed out during a conference this week.

The post CVS Health Exec: Payers Need to Stop Making Behavioral Health Providers Jump Through Hoops In Order to Participate in Value-Based Care appeared first on MedCity News.

CVS Health Corp. extended its rapid COVID-19 drive-thru testing sites to Michigan, with the launch of a new rapid COVID-19 drive-thru testing site in Dearborn in collaboration with federal and state officials. Since March, the company has conducted more than 35,000 COVID-19 tests. The new testing is part of CVS Health's efforts to expand access to coronavirus (COVID-19) testing for everybody.

Two severe security flaws have been discovered in the open-source SaltStack Salt configuration framework that could allow an adversary to execute arbitrary code on remote servers deployed in data centers and cloud environments. The vulnerabilities were identified by F-Secure researchers earlier this March and disclosed on Thursday, a day after SaltStack released a patch (version 3000.2)

This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Industry Update and COVID-19 Impact: PBMs & Payers.

Today's rerun highlights one of the most effective tactics that PBMs have developed to extract deeper discounts from brand-name drug makers. COVID-19 seems likely shift the U.S. payer mix away from commercial health plans. Expect even tighter formulary management and more restrictions as PBMs work even harder to cut costs for their plan sponsor clients.

Click here to see the original post and comments from January 2020.

---

For 2020, the two largest pharmacy benefit managers (PBMs)—Express Scripts and the Caremark business of CVS Health—have again increased the number of drugs they have excluded from their standard formularies. The 2020 formulary exclusion lists are available below for your downloading pleasure.

Below, I highlight my key takeaways from the 2020 lists:

• The number of exclusions

• Management of specialty drugs

• Indication-based formularies

• The slow adoption of biosimilars

• The PBMs’ patient-unfriendly exclusions in the hepatitis C category

Formulary exclusions have emerged as a powerful tool for PBMs to gain additional negotiating leverage against manufacturers. The prospect of exclusion leads manufacturers to offer deeper rebates to avoid being cut from the formulary. Exclusions are therefore a key factor behind falling brand-name net drug prices.

Read on for a look at this year’s exclusions along with some closing thoughts on what exclusions mean for patients.
Read more »

CVS Pharmacy Inc., the retail pharmacy division of CVS Caremark Corporation that operates more than 7,000 retail pharmacies in 41 states and the District of Columbia, has agreed to pay the United States and 10 states $17.5 million to resolve False Claims Act allegations.

In one of the first False Claims Act settlements involving Medicare’s Prescription Drug Program, known as Part D, RxAmerica LLC. has entered into a civil settlement agreement with the United States in which it has agreed to pay the government $5.25 million to resolve allegations that it made false submissions to the Centers for Medicare & Medicaid Services (CMS), the Justice Department announced today. RxAmerica, a wholly-owned subsidiary of CVS Caremark Corporation, provides prescription drug benefits to Medicare beneficiaries pursuant to a prescription drug plan.

Caremark LLC, a pharmacy benefit management company (PBM), will pay the government and five states a total of $4.25 million to settle allegations that it knowingly failed to reimburse Medicaid for prescription drug costs paid on behalf of Medicaid beneficiaries, who also were eligible for drug benefits under Caremark-administered private health plans.

The health-care company's chief executive, Larry Merlo, said trends that emerged during the pandemic, such as use of telemedicine and prescription delivery to the home, may continue to be popular.

The drugstore chain's stores have remained open as an essential retailer during the coronavirus pandemic, and it's also opened drive-thru testing sites.

The stocks making the biggest moves in premarket trading include GM, CVS, Shopify, Papa John's, Wendy's, and more.

CVS Health CEO Larry Merlo said the health retailer received validation that its strategy to make health care local is working.

Rolls out Blazo series as it targets market share to rise to 6%

Barker Library - TA355.V58 2012